|

OP-3136 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Olema Pharmaceuticals, Inc.1

Indications

  • Palazestrant1
  • Fulvestrant1
  • Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC)1
  • Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)1
  • Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)1

Sarasota, Florida1 trial

Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors

Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.